WO1997024989A1 - Heart valve prosthesis and method for making same - Google Patents

Heart valve prosthesis and method for making same Download PDF

Info

Publication number
WO1997024989A1
WO1997024989A1 PCT/US1997/000283 US9700283W WO9724989A1 WO 1997024989 A1 WO1997024989 A1 WO 1997024989A1 US 9700283 W US9700283 W US 9700283W WO 9724989 A1 WO9724989 A1 WO 9724989A1
Authority
WO
WIPO (PCT)
Prior art keywords
valve
stent
generally
prosthesis
holder
Prior art date
Application number
PCT/US1997/000283
Other languages
French (fr)
Inventor
William W. Angell
Original Assignee
Shelhigh, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US961196P priority Critical
Priority to US60/009,611 priority
Priority to US08/708,756 priority
Priority to US08/708,756 priority patent/US5855602A/en
Application filed by Shelhigh, Inc. filed Critical Shelhigh, Inc.
Publication of WO1997024989A1 publication Critical patent/WO1997024989A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices
    • A61F2/2412Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices
    • A61F2/2409Support rings therefor, e.g. for connecting valves to tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices
    • A61F2/2427Devices for manipulating or deploying heart valves during implantation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices
    • A61F2/2472Devices for testing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0096Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers
    • A61F2250/0098Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers radio-opaque, e.g. radio-opaque markers

Abstract

A natural tissue heart valve prosthesis (20) comprising a porcine valve (14) mounted in a cloth-covered, generally anatomical stent (22), is disclosed. The prosthesis includes an annular implantation flange (28) attached to the exterior base portion (24) of the stent between the inflow end and the outflow end of the stent base, and a pericardium strip (34) attached to at least a portion of the outflow rails (36) of the prosthesis to generally inhibit abrasion between the cusps (17, 18, 19) of the valve and the cloth covering (26) of the stent structure.

Description

TITLE HEART VALVE PROSTHESIS AND METHOD FOR MAKING SAME

TECHNICAL FIELD OF THE INVENTION

The present invention generally relates to a heart valve apparatus and method of making the heart valve apparatus More particularly, the present invention relates to an improved heart valve prosthesis of natural tissue cardiac valves that have been properly fixed in a solution and that may be mounted to an appropπate stent structure prior to implantation into the recipient

BACKGROUND ART

It is well known to utilize mechanical heart valves, such as the ball check valve, and natural tissue cardiac valves to replace defective aortic and mitral valves in human patients Referring to the natural tissue heart valves, porcine valves typically are utilized for implantation in humans, because they are very similar to human valves of appropriate size and generally are easy to procure. Pπor art teaches the concept of removing an aortic heart valve from a pig, treating it with a glutaraldehyde solution and mounting it into a stent, which may then be implanted into a patient for a heart valve replacement. Figure 1 illustrates such a pπor art heart valve prosthesis, generally indicated as 10, that includes a porcine cardiac valve 12 with a conventional stent construction 14. such as described and disclosed in U.S. Patent 3,983,581 and U.S Patent 4.035.849 both owned by William W Angell, the inventor of the present invention

While anatomically configured, natural tissue heart valve prostheses are well known in the art. conventional valves often are unable to achieve a completely adequate level of coaptation between the leaflets. In addition, due to the configuration of such heart valve prostheses, there tends to be a significant amount of abrasion between the leaflets of the porcine valve and the conventional stent structures, which generally further decreases the longevity of the valve apparatus Conventional stent structures are generally formed of a relatively rigid material that tends to be inflexible and difficult to manage by a surgeon during the implant procedure

Conventional prostheses are typically constructed with a nng of radio-opaque material affixed prosthesis within an implantation flange circumferentially positioned proximal the inflow side of the valve While the addition of such material, which may be viewed through fluoroscopy, may be beneficial duπng the post-implantation monitoring of the valve, it generally increases the outer diameter of the entire valve prosthesis and, thus, reduces the inner diameter to outer diameter ratio U S. Patent 5, 156,621 to Jose A

Navia discloses an unstented heart valve prosthesis that includes a suture ring having a continuous annular cord at the inflow side for implantation and a layer of a textile material covering the exterior of the entire structure U.S. Patent 4,759,758 to Gabbay discloses a heart valve prosthesis that includes a generally right-circular, cylindrical stent in which a single cusp formed of doubled-over pericardium is mounted. The exterior of the Gabbay prosthesis is completely covered with a biological tissue layer, such as pericardium A study of this and other such prior art heart valve prostheses readily leads one to the conclusion that such prior art generally fails to completely address the needs of a heart valve prosthesis.

SUMMARY OF THE INVENTION

In view of the foregoing, it is desired to provide an improved natural tissue, heart valve prosthesis that may provide an improved level of coaptation between the leaflets. It is also desired to provide a heart valve prosthesis that will resist wear due to abrasion between the cusps of the valve and the cloth covered stent stiuctures in which many valves are commonly mounted. It is still further desired to provide a natural tissue heait valve prosthesis that has an increased inner diameter to outer diameter iatio generally resulting in an improved flow orifice and improved hemodynamics. It is also desired to provide a heart valve prosthesis of substantially anatomical configuration. To achieve these and other objects that will become apparent, the present invention provides an improved natural tissue heart valve prosthesis primarily intended for replacing a patient's defective heart valve The prosthesis includes a tanned natural tissue heart valve having a generally cylindrical valve wall, an inflow end. an outflow end and plurality of cusps attached adjacent the inflow end of the valve and extending to a position proximal the outflow end The prosthesis also includes a stent having an inflow end, an outflow end and an annular base portion proximal the inflow end of the stent. The stent also includes at least three generally elongated posts integral with the stent that extend from the stent base in a generally parallel and spaced relation generally corresponding to the position of the cusps of the heart valve The valve is then attached within the stent such that the inflow end of the valve is positioned adjacent the inflow end of the stent with the outflow end of the valve positioned proximal the stent posts. In addition, a generally non-absorbent textile material covers at least a portion of the stent with an annular implantation plant attached to and circumscribing the base portion of the stent generally intermediate the inflow end and the outflow end of the stent base. In order to inhibit abrasion between the cusps of the heart valve and the textile covering the stent, a pericardium strip having first and second ends is attached generally to at least a portion of the textile material of the outflow end of the heart valve prosthesis

BRIEF DESCRIPTION OF THE DRAWINGS

Preferred embodiments of the present invention will be described in detail in respect to the drawings in which: FIGURE 1 IS a perspective view of a pπor art, natural tissue heart valve prosthesis;

FIGURE 2 is a schematic representation of a preferred fixation environment, partially in section, for fixing a natural tissue heart valve in accordance with the present invention,

FIGURE 3 IS a perspective view of a preferred embodiment of a trimmed natural tissue heart valve in accordance with the present invention,

FIGURE 4 IS a perspective view of a preferred embodiment of a natural tissue heart valve prosthesis in accordance with the present invention;

FIGURE 5 IS a side elevation of a preferred embodiment of a stent configured for a mitral valve heart prosthesis, FIGURE 6 is a side elevation of a preferred embodiment of a stent configured for an aortic heart valve prosthesis in accordance with the present invention;

FIGURE 7 is a top view of a preferred embodiment of an atπoventπcular valve holder in accordance with the present invention;

FIGURE 8 is a perspective view of a preferred embodiment of the valve holder of Fig 6 attached to a heart valve prosthesis with an appropriate attachment tool attached to the valve holder in accordance with the present invention,

FIGURE 9 is the heart valve prosthesis of Fig. 8 viewed from the outflow side of the valve prosthesis,

FIGURE 10 is a top view of a preferred embodiment of an aortic valve holder in accordance with the present invention.

FIGURE 11 IS a perspective view of a preferred embodiment of the valve holder of Fig. 10 attached to a heart valve prosthesis in accordance with the present invention;

FIGURE 12 is an exploded view of a preferred embodiment of a tπ-composite heart valve in accordance with the present invention; FIGURE 13 is a perspective view of a preferred embodiment of a tπ-composite heart valve in accordance with the present invention;

FIGURE 14 is a perspective view of a preferred embodiment of an unstented tπ- composite heart valve prosthesis in accordance with the present invention,

FIGURE 15 is an outflow perspective view of a preferred embodiment of a stented, tπ-composite aortic heart valve prosthesis in accordance with the present invention;

FIGURE 16 is an outflow perspective view of a preferred embodiment of a stented, tπ-composite mitral heart valve prosthesis in accordance with the present invention; and

FIGURE 17 is an inflow perspective view of a preferred embodiment of a stented. tπ-composite heart valve prosthesis with radio-opaque markers positioned on each stent in accordance with the present invention

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT

Prior to the assembly ot the heart valve prosthesis of the present invention, appropriate porcine valves that have no substantial anatomic abnormalities as well as no significant holes in the leaflets or cusps of the valve should be selected. The size of the porcine valve procured will generally depend upon the respective age of the heart valve donor animals Consequently, donors are appropriately selected in order to provide cardiac valves having an outside diameter typically ranging from about 17 to about 33 mm.

Once an appropriate valve has been selected, it preferably undergoes an appropπate fixation process to improve the tensile properties of the valves as well as improve its biocompatibility by decreasing tissue reactivity with the heart valve recipient This fixation process, shown in the schematic representation of Fig. 2, generally includes tanning the valve 14 in a container 8 having a predetermined glutaraldehyde solution 13 at a substantially constant temperature with a predetermined pressure being applied to the outflow side, generally indicated as 27, of the valve 14. While Fig. 2 shows a single porcine valve 14 undergoing appropriate fixation, it is to be understood that there will typically be a plurality of such valves being fixed at a given time. A suitable fixation environment 12 may include a .3 to .5 glutaraldehyde solution at a temperature ranging between 15°C and 25 °C with a pressure between 0 and 4 mm Hg being applied at the outflow side of the valve. A more preferred fixation environment includes approximately a .35 glutaraldehyde solution at about 20°C for at least 24 hours with about 2 mm Hg of pressure differential applied at the outflow side of the valve to assist in fixing the desired coaptation of the valve leaflets. After the initial tanning process, the valve may remain in the glutaraldehyde solution until it is required for inclusion in a heart valve prosthesis.

As shown in the schematic representation of Fig. 2, a preferred fixation process may include fitting a porcine aortic wall 16 that includes a valve, generally indicated as 14, with ring-like external and internal stems 23 and 25, respectively, mounted, with or without ligation, within the porcine aortic wall 16 proximal the outflow side 27 of the valve 14. The internal plug or stent 25 generally provides an attachment site to which appropriate pressure may be applied in order to maintain the valve 14 in a substantially closed position and achieve a desired coaptation between the cusps 17, 18 and 19. The pressure may be applied to the outflow side 27 by a conventional source (not shown) through an appropriate interface, such as tube 15, and may be monitored by a standard pressure gauge 33 to ensure that the pressure differential between the outflow side 27 of valve 14 and the surrounding solution 13 remains at a preferred level. In addition, ring shaped external and internal stent 23 may also be mounted to the inflow side, generally indicated as 31 , of the valve 14 during the fixation process to maintain a preferred substantially circular shape as well as to promote the desired coaptation, suitably about 2mm to about 4mm of generally axial engagement, between the cusps 17, 18 and 19. The external and internal stents 23 typically are positioned circumferentially with respect to the external and internal circumferences of the aortic wall 16 of valve 14 proximal the inflow side 31 of the valve 14. Typically, the plug 25 and the internal and external stents 23, respectively, employed during fixation are selected to correspond to the size of the particular porcine valve 14 that is to be tanned and to the shape of the stent.

After the porcine valve 14 undergoes the fixation process, it may be appropriately trimmed for inclusion into a heart valve prosthesis, as shown in the premounted value of Fig. 3, and typically includes cutting generally along the contour of the attachment of the cusps to the valve wall proximal the inflow and outflow ends 31 and 27, respectively, of the aortic valve 14. The fixed porcine valve 14 includes a generally cylindrical valve wall 16, an inflow end, an outflow end and three cusps 17, 18 and 19 that are integrally attached adjacent the inflow end of the valve 14 and extend along a portion of the valve wall 16. Along the outflow rail proximal each cusp 17, 18 and 19, a portion of the valve wall 16 may be removed to define three radially spaced posts with sinuses formed between each adjacent cusp 17, 18 and 19.

Fig. 4 illustrates a preferred embodiment of a heart valve prosthesis, generally indicated as 20, that includes the trimmed porcine valve 14 of Fig. 3 mounted or attached within in a conventional stent, generally indicated as 22. Suitable stent structures include those disclosed in U.S. Patent 3,983,581 and U.S. Patent 4,035,849 both owned by William W. Angell, the inventor of the present invention as well as other structures well known in the art. Such stents 22 are preferably formed of thermoplastic materials, such as the material known commercially as Delrin, and may be manufactured, suitably by injection molding, in various sizes and shapes. For the preferred embodiment illustrated in Fig. 4 such stent structures 22 typically include at least, and preferably, three asymmetrically radially spaced and elongated stent posts 42, 44 and 46 extending from the annular base portion 24 that correspond generally to the anatomy of the heart valves such as shown in Fig. 3. Preferably, the stent posts 42, 44 and 46 are radially spaced apart along the outflow end of base portion to generally correspond to the radial positioning of the individual cusps of the heart valve 14. Such stent 22 also includes an inflow end 30, an outflow end 32, an interior and an exterior. At least a portion, although preferably the entire stent structure 22 is generally covered with a nonabsorbent textile or fabric cover 26, such as by sewing an open mesh Dacron polymer cloth or an equivalent material over the internal and external surfaces of the stent 22. Preferably, the valve 14 is attached, such as by sutures, within the stent structure 22 such that the inflow end of the valve 14 is positioned adjacent the inflow end of the stent with the outflow end 27 of the valve positioned proximal and preferably conforming to the configuration of the stent posts. A generally annular implantation flange 28 may be attached to and circumscribe the exterior of the stent base 24 intermediate the inflow end 30 and the edge 32 of the stent. The flange 28 is suitably formed by sewing the flange 28 in the Dacron covering 26 that surrounds the stent 22 Preferably, the flange 28 includes an additional ring of Dacron material interposed between the top and bottom portions of the flange 28, such as by sewing, and may suitably be ironed pπor to implantation to form a substantially flat ring¬ like structure circumscribing the stent base 24. As shown in Figs 4 and 5, the positioning of the implantation flange 28 will typically depend upon whether the porcine heart valve 20 will be implanted as a mitral valve, shown in Fig 4. or an aortic valve, shown in Fig. 5 The implantation flange 28 for the aortic valve of Fig. 5 is preferably positioned generally adjacent to the inflow or ventricular edge 30 of the stent base portion 24, and the implantation flange 28 in the mitral valve shown in Fig 4 is positioned substantially adjacent the outflow or aortic edge 32 of stent base 24

Appropπate radio-opaque markers 39. which may suitably be formed of barium, silicone, a metal foil or other suitable materials known in the art preferably are positioned substantially longitudinally along at least one, although preferably each of the stent posts 42, 44 and 46 beneath the Dacron covering 26. By positioning the markers 39 along the stent posts 42, 44 and 46 rather than conventionally within the implantation flange 28, the inner diameter to outer diameter ratio of the valve will generally increase, resulting m an improved flow orifice and. consequently, improved blood flow through the implanted prosthesis

Once an aortic porcine valve 14 has been mounted appropriately to the Dacron covered stent 22, a pericardium strip 34 having first and second ends, which may suitably be equine or porcine pericardium or other suitable generally smooth biocompatible material is attached, such as by suture 35. to at least a portion of the textile material of the outflow end 32 of the prosthesis 20. Preferably the strip 34 is attached along the outflow rails 36 of the stent 22 and the free margins 38 of the valve that are proximal the outflow ends of the respective stent posts 43, 45 and 47 and generally intermediate the posts beyond the attachment of the cusps to the valve wall 16. The pericardium strip 34 provides a natural tissue material for the valve leaflets to open against, which tissue is smoother than woven Dacron and, thus, generally inhibits the abrasion that typically occurs between the valve leaflets and the Dacron covering 26 as the leaflets permit the flow of blood. Preferably. the tanned strip of pericardium 34 is affixed to the heart valve prosthesis 20 such that its visceral, or smooth, side is exposed, and it may be tanned in a suitable glutaraldehyde solution In addition, the strip 34 also tends to improve the compatibility between the heart valve prosthesis 20 and the valve recipient The butt seam 40 of the pericardium strip 34 is preferably positioned along the side of one of the stent posts intermediate the post tip 43 and the stent base portion 24. with the two ends of the pericardium strip 34 seamed together end to end with substantially no overlap to define seam 40 In a relatively small sized valve prosthesis (not shown), the pericardium bias may be omitted with a continuous aortic margin stitch securing the aortic wall of the valve 14 to the outflow stent rails Once the heart valve prosthesis 20 has been assembled as set forth above, it preferably may be attached to an appropriate valve holder, such as illustrated in Figs. 6 through 10, that may vary in construction depending upon whether the valve prosthesis is intended to replace an aoitic valve or a mitral valve Such holders may be injection molded and formed of a generally resilient mateπal such as the commercially available Delrin In general, the valve holders of Figs 7 through 1 1 maintain the valve prosthesis in a preferable configuration duπng storage as well as facilitate the implantation procedure by the surgeon.

Figs 7. 8 and 9 illustrate an atπoventπcular valve holder 160 that is attachable to a heart valve prosthesis, generally indicated as 120 in Fig 9, which may be configured for mitral valve replacement, at the inflow side 131 of the valve prosthesis 120 It will be understood that the valve holder 160 is well suited tor, but not limited to. such mitral valve replacement For simplification of illustration, reference numbers in the view of Fig 8 that correspond to parallel components of the heart valve prosthesis 20 of Fig 4 have been increased by adding a factor of 100. The atπoventπcular valve holder 160. having an upper side, generally indicated as

172. and a lower side, generally indicated as 173. preferably includes at least three spokes 161, 162. and 163 that attach to and extend between an annular ring 164 having two sides and an inner central base portion 166 having a central axis Of course, a substantially solid member extending between base 166 and ring 164 may suffice in place of the individual spokes 161 , 162 and 163 At least one hole, although preferably 2 or more holes 167, 168 and 169 are bored through each respective spoke 161 , 162 and 163 proximal the attachment, or juncture, of the annular ring 164 and the spokes 161 , 162 and 163 The preferred embodiment of the base 166 further includes a holder attachment 170 which is illustrated as a generally hollow cylinder extending generally upwardly from a generally planar surface of the base 166 that generally surrounds the holder attachment 170. The holder attachment 170 suitably includes an aperture 171 formed through at least a portion of the base 166 generally along the axis of the valve holder 160, with the holder attachment 170 being dimensioned and configured for receiving a tool, generally indicated as 175 in Fig. 9 The valve holder 160 preferably also includes at least one. although preferably a plurality of projections or suture tabs 165 that extend generally upwardly from the base portion 166 a predetermined length. Preferably, the tabs 165 are radially spaced apart from and generally surround the holder attachment 170. with each such tab 165 preferably positioned generally intermediate each adjacent pair of holes 167, 168 and 169, such that a suture may conveniently be positioned between the holder attachment 170 and a respective tab 165, shown as phantom lines 177 in Fig. 8.

The annular ring 164 of the holder 160 includes two sides, with the lower side preferably dimensioned and configured for engaging the inflow base portion 131 of a valve prosthesis 120 and may be secured to the valve prosthesis 120 by appropriate suturing through the plurality of holes 167. 168, and 169. Preferably, three individual sutures, each having first and second ends, are used to secure the valve holder 160 to inflow end 131 of the heart valve prosthesis 120. It will be understood and appreciated that while the prosthesis 120 illustrated in Fig 9 is a preferred natural tissue valve prosthesis appropriately configured for mitral valve replacement, such as described with respect to Figs 4 and 5. the holder 160 may conveniently be adapted to implant substantially any heart valve prosthesis, although preferably to replace a mitral valve. With the valve 120. for example, lower side 173 of holder 160 engages the inflow end 131 of valve 120, with the axis of the holder generally aligned with the axis of the valve and each commissure post 142. 144 and 146 generally aligned with a respective spoke 161. 163 and 162 of the holder proximal said holes 167. 168 and 169. respectively Each post 142. 144 and 146 includes a post tip 143, 145 and 147 distal the inflow end 131 A suture 104 extends through one hole 167 of the holder 160 and extends down the length of the respective post 142, through the implantation flange 128 adjacent the post exterior surface and through the post tip 143, suitably through the pericardium strip 132 covering the tip 143 The suture 104 then extends across to an adjacent post tip, suitably tip 147 of post 146. through the tip 147, suitably through the pericardium 132 that covers tip 147. and then extends generally along the exterior of post 146 through the implantation flange 128 to the hole 168 of the valve holder 160, where it is appropriately secured, such as by tying, to the other end of suture 104 to provide an appropriate amount of tension in the suture 104. In a similar manner, two additional sutures may secure the valve holder 160 to the valve prosthesis 120 by connecting between the holes 168 and 169 and the holes 169 and 167. These additional sutures 105 and 106 extend, for example, from a respective hole 168 or 169, down the length of the post 146 or 144. through the implantation flange 128, through the pericardium strip 132 covering the post tip 147 or 145, over to on adjacent tip 145 or 143, through the pericardium 132 covering the respective tip 145 or 143, extend upward along the post 144 or 142 and through the implantation flange 128 to a respective hole 169 or 167. The two ends of the respective sutures 105 and 106, that extend through holes 167 and 169, and 168 and 169. respectively, are tied off, maintaining an appropriate amount of tension in each suture 105 and 106. When viewed from the outflow side of the valve 120, the sutures 104, 105 and 106 are in place, they collectively form a generally triangular shaped suture, generally indicated as 1 10, connecting between the three post tips 143. 145 and 147, shown in Figs. 8 and 9.

Prior to implantation of the valve prosthesis 120. each suture extending between each pair of respective spokes are generally moveable in that they may provide traction to the posts 142. 144 and 146 by positioning the respective sutures 104, 105 and 106 between a proximal respective suture tab 165 and the holder attachment 170, shown by phantom lines 177, to a position of engagement with the respective proximal tabs 165. The tractioning of each suture 104, 105 and 106 with the tabs 165 generally urges the pair of adjacent posts through which each such suture extends generally inwardly toward the central axis of the valve prosthesis 120. This substantially reduces "looping" of the posts 142. 144, and 146 with the surgeons implant stitches during the implantation procedure. The valve prosthesis 120 and valve holder 160 combination shown in Fig. 8 is generally positioned within a patient's atπoventπcular orifice by a substantially elongated tool 175 that may be connected to the holder attachment 170 of the valve holder 160. Preferably, the elongated shaft 174 of tool 175 is made of a substantially lightweight and flexible alloy material or the like, and may be discarded after the implant procedure In addition, because of the convenient attachment of the holder 160 to the valve heart prosthesis 120. the atπoventπcular valve holder 160 as well as the attachment tool 175 illustrated in Figs 7, 8 and 9 may remain attached to the mitral valve prosthesis 120 during a substantial portion of the implantation procedure, suitably until the implantation flange 128 has been anchored appropriately to the patient's atπoventπcular orifice. Once the valve prosthesis 120 has been anchored to the orifice, the sutures 104. 105 and 106 may be easily removed, suitably by severing each structure, along with the valve holder 160. Allowing the valve holder 160 and attachment tool 175 to remain attached to the valve prosthesis 120 during the implantation procedure greatly facilitates the implantation of the mitral replacement valve. Referring to Figs. 10 and 1 1 , where the reference numbers of corresponding components of the heart valve prosthesis of Fig. 4 have been increased by adding 200, an aortic valve holder, generally indicated as 250. may be attached to an aortic heart valve prothesis 220. The valve holder 250 preferably includes an axial base portion 251 with three arms 253, 255 and 257 spaced apart and extending from the base 251 and configured for attachment to a heart valve prosthesis 220. However, rather than attaching to the inflow side 231 as the atπoventπcular valve holder in Fig. 7, the aortic holder 250 may be attached, such as by suture, at the outflow side 227 of the heart valve prosthesis 220. Preferably, the post tips 243, 245 and 247 of the prosthesis fit into and engage the respective receptacles 254, 256. and 258 of the valve holder 250, shown in Fig. 1 1. In order to facilitate the sutuπng between the holder 250 and the valve prosthesis 220, a plurality of holes 267. 268 and 269 preferably extend through each arm 253, 255 and 257 proximal the respective receptacles 254, 256 and 258 In this manner, three simple sutures may secure the holder 250 to the valve 214. with each suture preferably passing through a respective one of the plurality of holes 267, 268 and 269, extending through the pericardium 232 covering the tips 243, 245 and 247 of the aortic heart valve prosthesis 220. extending to and anchoring in the implantation flange 228. Each suture then may extend along a respective stent post 242, 244 and 246, pass through the pericardium strip 232. extend through a respective one of the plurality of holes 267. 268 and 269 and be appropriately tied off. The valve holder 250 generally piovides passive support to the tips 243, 245 and 247 and may be attached to an appropriate attachment tool, similar to that described with respect to the embodiment of Fig. 8.

Figures 12 through 17 are directed to alternative preferred embodiments of the present invention that generally include a composite cardiac valve prosthesis having three leaflets 302. 304 and 306. each preferably being the non-coionary leaflet of a porcine aortic heart valve Such non-coronary leaflets are obtained preferably from porcine aortic valves that have undergone an appropriate fixation process, such as described above with respect to Fig. 2 The non-coronary leaflets, as opposed to coronary leaflets, generally enhance the durability of the composite valve because of the fibrous attachment of each cusp to its respective valve wall. Once the porcine valves have undergone the appropπate fixation process, each prospective leaflet may be excised from an appropriate porcine valve for inclusion in the valve prostheses illustrated in Figs. 12 through 17 These excised leaflets, generally indicated as 302, 304 and 306, are carefully examined and matched with leaflets of similar size, shape and symmetry, shown in Fig 12. and may be temporarily attached to each other, such as by suture, in order to ensure that the three leaflets are suitable matches to form a substantially symmetrical tπ-composite valve. Matching the leaflets in this manner generally provides an improved operation of the composite valve, including substantially simultaneous opening and closing of the valve leaflets, and, consequently enhanced hemodynamics and efficiency of the valve 301. Each such leaflet suitably includes a valve wall 303, 305 and 307 and a cusp 309, 31 1 and 313, with each valve wall 303, 305 and 307 further including a pair of generally opposed side edges 308, 310 and 312, an inflow edge and an outflow edge. Each cusp 309, 31 1 and 313 is attached to and extends from its respective valve wall 303, 305 and 307 proximal its inflow edge, suitably integral with the valve wall 303, 305 and 307 The outflow edge of each leaflet preferably has at least a substantial portion of excess valve wall tissue removed generally along the attachment of each cusp and its respective valve wall 303, 305 and 307 to form a sinus 351 , 353 and 357 between the side edges of each valve wall. It is preferable that substantially little, if any, free margin remains beyond such attachment.

The tanned leaflets 302. 304 and 306 are selected to be suitable for inclusion in a heart valve prosthesis and are assembled to form a tπ-composite valve 301 such as that illustrated in Fig. 13. The leaflets aie preferably stitched at their respectively adjacent cut side edges 308, 310 and 312 of the valve walls along the outside surface of each commissure 314, 316 and 318 between the respective leaflets 302, 304 and 306, such as by a continuous ladder stitch 315 and 317. with the attachment between the valve walls of adjacent leaflets defining each commissure post 321. 323 and 325 between each leaflet sinus 351. 353 and 357 A single stitch 320 may be exposed on the internal side of the valve 301 along each commissure 314. 316 and 338 proximal the top edge 322, 324 and 326 of each commissure post 321. 323 and 325, respectively A continuous stitch may be placed around the inflow end of the base portion of the composite valve to inhibit delamination of the valve In addition, as illustrated in the preferred embodiment of Fig 13, the top edges 322, 324 and 326 of each commissure post 321 , 323 and 325, respectively, preferably are cut substantially flat just above a top commissure stitch with the sides of each post proximal the top edges cut at an appropriate angle. Of course, the top edges 322, 324 and 326 of each respective commissure post 321 , 323 and 325 may be substantially curved or flat rather than be substantially flat with such angled corners.

The tπ-composite valve 301 should be assembled such that there is substantial coaptation. or generally axial engagement, between each of the cusps 309. 31 1 and 313, which preferably ranges between about 2 mm and about 4 mm, or approximately 50% of the cusp surfaces when the valve is in its closed position. This preferred leaflet coaptation may be enhanced during the fixation process as described above as well as by the selecting of substantially symmetrical leaflets for inclusion in the heart valve 301. The difference in length between each adjacent free margin 327, 328 and 329 is preferably less than about 3 mm, depending generally upon the size of the tπ-composite heart valve 301 In addition, it is preferable that substantially little, generally less than about 3mm. if any, valve wall extends beyond the attachment of each cusp 309. 31 1 and 313 and its respective valve wall at the outflow end 327 of the composite valve 301 Accordingly, the tn-composite heart valve 301 is similar to the porcine heart valve shown in Fig. 3, and will often experience improved performance because of the desired level of coaptation resulting from the selection and assembly of the individual and generally same size, symmetrical leaflets The tn-composite valve 301 may be mounted in an appropriate anatomical stent, typically ranging in thickness from zero to about 1 mm, with zero referring to an unstented heart valve 301.

A preferred embodiment of the unstented heart valve is shown in Fig. 14 in which, for simplicity of illustration, similar reference numbers increased by adding 100 indicate corresponding components of the valve of Fig. 13. In order to facilitate the implantation of an unstented heart valve prosthesis 401. a peπcardial bias 410 may be secured to the exterior surface proximal the base 430 of the unstented. tπ-composite heart valve prosthesis 401 to provide support to the unstented heart valve 401 as well as provide additional structure that may be sutured to. or positioned proximal, an appropriate valve orifice. Base portion 430 is defined by the valve wall portion extending generally between the valve inflow edge 431 and sinuses 451. 453 and 457 circumferentially around valve prosthesis 401 Preferably, the bias 410 includes a pair of side edges 41 1 and 412 that are dimensioned and configured to substantially conform to the contour of the inflow and outflow ends of the base portion 430 of the unstented valve prosthesis 401. The inflow side edge 41 1 of bias 410 is attached proximal the inflow edge 431 of valve 401 , with the other side 412 being attached along the base outflow end A pericardium bias 410 generally will not abrade the valve leaflets or the patient's valve orifice as may the textile material covering many conventional prostheses

In addition to the inclusion pericardium bias 410. the valve wall tissue is preferably trimmed from the valve leaflets 402, 404 and 406 beyond the attachment of each cusp 409, 41 1 and 413 and its respective valve wall 403. 405 and 407 to form substantially narrow commissure posts 421. 423. and 425 that are substantially free of excess valve wall tissue along their respective side edges. This preferably includes removing excess valve wail tissue from each leaflet outflow end intermediate each commissure post 421 , 423, and 425 to further enlarge and define each sinus 451 , 453 and 457 formed between adjacent posts 421 , 423 and 425. In addition, as is further shown in Fig. 14, this also preferably includes further trimming the valve wall tissue proximal the top edges 422. 424 and 426 of each respective commissure post 421. 423 and 425 at angles that may be substantially greater than that of the tn-composite valve illustrated in Fig. 13 such that the side edges of each post 421, 423, and 425 taper, or decrease in distance, toward the generally flat top edges 422, 424 and 426 The narrower posts and steeper angles of the top edges 422, 424 and 426 of the respective commissure posts and the peπcardial bias 410 generally facilitate the implantation of the unstented heart valve prosthesis 401 , as well as provide for increased flexibility and durability of the valve prosthesis In addition, removing such valve wall tissue also permits a larger valve with a larger flow orifice to be used for a given patient, thereby increasing the available operative hydraulic performance of the valve prosthesis. While the unstented heart valve prosthesis 401 may require a greater degree of surgical proficiency to implant, it generally is more compatible with human recipients as it comprises virtually only tanned natural peπcardial tissue, except for its sutures The stent 319 in which the tri-composite heart valve 301 illustrated in Fig. 13 may be mounted is substantially identical in construction to those utilized in conjunction with the heart valve embodiment illustrated in Fig. 4 but are preferably less rigid. The stents are formed of a resilient material, suitably Delrin. with a generally cylindrical sidewall portion having a generally uniform sidewall thickness of less than about 1 mm. Depending on the desired rigidity of the stents. its sidewall portion may vary in thickness, preferably ranging from about 0.25 mm to about 1.00 mm. In addition, because the tri-composite valve 301 is substantially symmetrical, the stent in which it is to be mounted should also be substantially symmetrical. Thus, the tri-composite heart valve 301 is preferably mounted to an appropriately sized and shaped Dacron-covered, symmetrical stent 319 such as by suturing the exterior of the valve 301 to the Dacron covering 331. Such sutures may include about three spaced apart stitches along the exterior of each commissure 314, 316 and 318 and sutures along the annular base portion 330 that further inhibit delamination of the valve 301 . Preferably no stitches from mounting valve 301 to the stent 319 are exposed on the internal side of the valve 301. Of course other stitching configurations may be used with equal facility. In addition, each commissure post 321 , 323 and 325 is suitably dimensioned and configured to generally correspond to the posts of the stent in which the valve 301 is to be mounted.

As shown in Figs. 15 and 16, an appropriate tissue strip 332, which may suitably be equine or porcine pericardium, is attached to at least a portion of the outflow rail 335, preferably the entire outflow rail 335. of the stented. tri-composite valve 333, preferably with the visceral side of the pericardium strip 332 being exposed. The butt seam 340 of the pericardium strip 332 is preferably positioned along the side of one of the commissure posts intermediate the tip and the base portion of a post as shown in Figs. 15 and 16. Preferably, the two ends of the pericardium strip 332 are seamed together end to end at seam 340 with no overlap and are affixed to the prosthesis 333 with no stitches being exposed to the valve leaflets 302, 304 and 306. Accordingly, the pericardium strip 332 may inhibit the abrasions that might otherwise result from the leaflets 302, 304 and 306 engaging the Dacron covering 331 of the stent structure. A relatively small composite valve may not have pericardial covering but. rather, a continuous aortic margin stitch may be employed to secure the aortic wall of the tri-composite valve to the outflow stent rails (not shown). Figs 15 and 16 illustrate an embodiment of the present invention where the heart valve is mounted within a relatively thin stent 319, having a sidewall thickness of less than about 1 mm, in which a support is attached to the exterior of each stent post and to the implantation flange 342 Fig. 15 illustrates a prosthesis generally configured for aortic valve replacement with a V-shaped support 338. suitably formed of a textile material such as commercially available Dacron Each V-shaped support has first and second ends 360 and 361 positioned distal from an apex 341 , with the apex 341 attached proximal the tip of each respective stent post 346. 348 and 350 The first and second ends 360 and 361 of each V-shaped support 338 are attached to the flange on the opposing sides of the apex, with the width of each V-shaped support 338 typically ranging between about 1 3 mm and about 3.0 mm, generally less than or equal to the width of the implantation flange, oriented substantially transverse to each stent post 346, 348 and 350.

Fig. 16 illustrates a preferred embodiment of a tn-composite heart valve prosthesis configured for mitral valve replacement mounted in a relatively thin stent 519 Similar reference numbers, increased by adding 200, refer to parallel elements shown in Fig 15. The stent 519 includes a support similar to Fig. 15, but with a support web 560 of a cloth material, which may suitably be Dacron, attached to the exterior of each stent post 546, 548 and 550 in order to provide additional support to each stent post 546, 548 and 550. The support web 560 may suitably be formed by folding the cloth generally in half to form a sail-like web that may be anchored, such as by suture, along each stent post with its fold aligned generally with the commissure between each of the three leaflets Each support web includes a generally V-shaped base portion 562, an apex 561 and a pair of generally opposed side edges extending between the apex 561 and the base portion 562. The center portion of base 562 is attached to the outflow side of the implantation flange 542 radially outwardly from each respective post, with the distance between the side edges at a maximum adjacent the respective commissure post 548, 546 or 550 and flange 542. At least a portion of the side edges 563 and 564 of the web 560 engage, or preferably are attached to, the exterior of a respective commissure post 546, 548 and 550 with the distance between opposing side edges 563 and 564 decreasing in distance from the implantation flange 542 toward the apex 561 Preferably, the apex is attached proximal the tip of a respective post 546, 548 and 550 Accordingly, during the implantation procedure each support web 560 may suitably be anchored to a patient's atπoventπcular orifice or surrounding tissue to reinforce the stent post 546, 548 and 550 and inhibit their inward deflection It will be understood and appreciated that each of the supports illustrated in Figs 15 and 16 are equally applicable to prostheses configured for mitral or aortic valve replacement As illustrated in the preferred embodiment of Fig 17, radio-opaque markers 643 in the shape of thin strips may be positioned along each stent post Similar reference numbers, increased by adding 301 . refer to corresponding elements shown in Fig. 15. Preferably, such radio-opaque markers 643 are positioned substantially longitudinally along the exterior of each elongated stent post 646, 648 and 650 beneath the Dacron covering. By moving the radio-opaque markers 643 from the implantation flange 642, to the stent posts, as discussed with respect to Fig. 4. the overall flow rate of the heart valve orifice may be improved as a result of the increase in the inner diameter to outer diameter ratio of the heart valve prosthesis 633 This typically allows the physician to utilize a valve prosthesis that has a larger flow orifice than most conventional valves of comparable size. Such radio-opaque markers 643 may also be used in conjunction with the supports of Figs. 15 and 16, suitably positioned intermediate the two legs of the V-shaped support 338 of Fig. 15 beneath the Dacron covering of the stent 319 or between the side edges of web 560 beneath the Dacron covering of stent 519. Fig. 17 also illustrates the preferred symmetry of the leaflet cusps 602, 604 and 606, and is illustrated in the context of a valve prosthesis 633 configured for aortic valve replacement with the implantation flange 642 positioned adjacent the inflow end 631 of the prosthesis 633

In order to facilitate the implantation of the stented. tn-composite valve prosthesis 333, the position of the implantation flange 342 on the tn-composite, stented heart valve prosthesis may vary as discussed with respect to the alternative preferred embodiment of Fig 4. and the positioning of the flange 342 with respect to the inflow end 331 , and may even be more pronounced Thus, where the valve prosthesis 333 is an aortic replacement valve, the implantation flange 342 is positioned preferably substantially adjacent to the inflow edge 331 of valve 301 , similar as shown in Fig 6 In contrast, the implantation flange 342 for mitral valve preferably is positioned proximal to the outflow or aortic end 327, such as illustrated in Fig. 5

In order to further facilitate the implantation of the stented. tn-composite valve prosthesis 333 and 533 shown in Figs 15 and 16. lespectively, appropriate valve holders may be attached to the inflow or outflow edge of the valve prosthesis The valve holders and the attachment of each valve prosthesis to the respective holders are substantially identical to those shown and described with respect to the preferred embodiments of Figs 7 through 1 1. other than the radial placement of the spokes of such holders being substantially symmetrical to correspond to the configuration of the valve prosthesis The preferred valve holder configuration and the attachment of the valve holder to the valve prosthesis generally depends upon whether the valve prosthesis is an aortic valve prosthesis or a mitral valve prosthesis. The post tips 343. 345 and 347 of an aortic replacement valve prosthesis 333 preferably may fit snugly into and be sutured to the respective receptacles 254, 256 and 258 of the valve holder 250, substantially as shown and described with respect to Figs 10 and 1 1 As stated above, the aortic valve holder 250 provides a substantially passive support to the valve prosthesis 333 during implantation

Similarly, a substantially symmetrical mitral valve holder similar to that illustrated in Figs 7. 8 and 9 may likewise be secured to the inflow edge 531 of a heart valve prosthesis, such as the tn-composite. stented valve prosthesis 533 that has been configured appropriately for mitral valve replacement, similar to as shown in Fig. 8 Preferably, as described with respect to Figs. 8 and 9, three sutures 104, 105 and 106 collectively form a triangle shape suture 1 10 between the three stent post tips 143, 145 and 147 Tension may be applied to the sutures 104, 105 and 106 prior to implantation such that the posts 142. 144 and 146 of the valve will bend slightly inwardly above the valve holder 160 to inhibit "looping" of the posts with a surgeon's implant stitches As stated above, this may be accomplished by positioning each suture 104, 105 and 106 generally around the iespective pioximal suture tabs 165 substantially as shown and described with respect to

Numerous variations in modifications of the present invention, all within the scope of this invention, will readily occur to those skilled in the art. All such modifications and variations are considered to be fully within the scope of this invention, and the forgoing detailed description is to be considered illustrative only of the principles of this invention and not limitative thereof. The scope of the present invention is to be determined solely by the claims appended hereto.

Claims

WHAT is CLAIMED is:
1 . A natural tissue heart valve prosthesis primarily intended for replacing a patient's defective heart valve, said prosthesis comprising: a tanned natural tissue heart valve having a generally cylindrical valve wall, an inflow end. an outflow end, and a plurality of cusps attached adjacent said inflow end of said valve and extending to a position proximal said outflow end: a stent having an inflow end. an outflow end, an annular base portion proximal said stent inflow end and at least three generally elongated posts extending from said stent base in a generally parallel and spaced apart relation that generally corresponds to the position of said cusps, said stent having interior and exterior portions, and said valve attached within said stent such that said inflow end of said valve is positioned adjacent said inflow end of said stent with said outflow end of said valve proximal said posts; a generally nonabsorbent textile material covering at least a portion of said stent; and a pericardium strip having first and second ends attached to at least a portion of said textile material of said outflow end of said prosthesis to inhibit abrasion between said cusps and said textile material covering said stent.
2. A heart valve prosthesis as claimed in claim 1 wherein said strip further comprises a visceral side that is exposed in its attachment to said prosthesis.
3. A heart valve prosthesis as claimed in claim 1 wherein said strip further comprises equine pericardium that has been tanned with glutaraldehyde.
4. A heart valve prosthesis as claimed in claim 1 wherein said strip further comprises porcine pericardium that has been tanned with glutaraldehyde.
5. A heart valve prosthesis as in claim 1 wherein said prosthesis further includes a free margin proximal said outflow end and intermediate each adjacent said stent post with said pericardium strip attached to at least a portion of said free margin and said outflow end.
6. A heart valve prosthesis as in claim 5 wherein said strip is attached to said outflow end of said prosthesis such that said first and second ends of said strip abut with substantially no overlap.
7 A heart valve prosthesis as in claim 1 further comprising an annulai implantation flange attached to and circumscribing said exterior base portion of said stent intermediate said inflow end and said outflow end of said stent base portion.
8 A heart valve prosthesis as in claim 7 wherein said flange is positioned generally adjacent said inflow end of said stent.
9 A heart valve prosthesis as in claim 7 wherein said flange is positioned distal said inflow end of said stent base.
10 A heart valve prosthesis as in claim 9 wherein said flange is positioned substantially adjacent said outflow end of said base of said stent.
1 1 . A heart valve prosthesis as in claim 1 further comprising a radio opaque marker affixed positioned generally longitudinally along at least one of said stent posts beneath said textile material
12. A heart valve prosthesis as in claim 1 1 further comprising a radio opaque marker attached generally longitudinally to each said stent post beneath said textile material.
13. A heart valve prosthesis as claimed in claim 1 in combination with a valve holder, said combination comprising- a valve holder comprising: an inner base portion having a central axis; a generally annular ring having two sides; at least two spokes attached to and extending between said annular ring and said inner base portion, each said spoke including at least one hole formed through said valve holder proximal said attachment of said annular ring and said spoke; and at least one retaining tab extending upwardly from said inner base portion spaced from and surrounding said base portion axis; said annular ring of said holder positioned adjacent said inflow end of said valve prosthesis with said axis of said valve generally aligned with said axis of said holder, each of said posts aligned generally with a respective one of said spokes proximal said annular ring, and a plurality of sutures, each said suture having first and second ends and extending through one of said holes of said holder, through the respective proximal post distal end, through an adjacent post distal end and through said hole of the respective spoke of said adjacent post distal end, and said first and second ends being secured together, with a portion of said suture positioned between adjacent said spokes being moveable to a position of engagement with the respective proximal said tab such that, when said suture engages said tab. the pair of adjacent posts through which said suture extends are urged toward said axis of said valve prosthesis.
14. A valve holder primarily intended for mitral valve replacement, said valve holder comprising: an inner base portion having a central axis; a generally annular ring having two sides; at least two spokes attached to and extending between said annular ring and said inner base portion, each said spoke including at least one hole formed through said valve holder proximal said attachment of said annular ring and said spoke; and at least one retaining tab extending upwardly from said inner base portion spaced from and surrounding said base portion axis.
15 A valve holder as in claim 14 further comprising at least three said spokes radially spaced apart and extending between said inner base portion and said annular ring.
16 A valve holder as in claim 15 further compπsing at least one hole formed through each said spoke generally adjacent said annular ring.
17 A valve holder as in claim 16 further comprising a retaining tab extending from said base portion of said holder generally intermediate each pair of adjacent said spokes
18. A valve holder as in claim 14 wherein said base further comprises a holder attachment having an aperture formed through at least a portion of said inner base generally portion generally along said axis, said holder attachment dimensioned and configured for receiving a tool.
19 A valve holder as in claim 14 wherein said annular ring has an upper side and a lower side, with said lower side dimensioned and configured for a generally mating relationship with a heart valve prosthesis inflow base portion.
20. A valve holder as in claim 14 in combination with a heart valve prosthesis, said combination comprising: a heart valve prosthesis having an axis and a base portion with an inflow end and an outflow end, and a plurality of posts extending from said base portion with each post having an end distal said base portion, said annular ring of said holder positioned adjacent said inflow end of said valve prosthesis with said axis of said valve generally aligned with said axis of said holder, each of said posts aligned generally with a respective one of said spokes proximal said annular ring, and a plurality of sutures, each said suture having first and second ends and extending through one of said holes of said holder, through the respective proximal post distal end, through an adjacent post distal end and through said hole of the iespective spoke of said adjacent post distal end, and said first and second ends being secured together, with a portion of said suture positioned between adjacent said spokes being moveable to a position of engagement with the respective proximal said tab such that, when said suture engages said tab. the pair of adjacent posts through which said suture extends are urged toward said axis of said valve prosthesis. 21 A combination as in claim 20. wherein said heart valve prosthesis further comprises an annular implantation flange circumscribing said valve prosthesis intermediate said base inflow and outflow ends, with each said suture extending along each said commissure post passing through said flange
22 A combination as in claim 21 wherein said flange circumscribes said base portion distal said base inflow end of said valve prosthesis
23 A method of making a heart valve prosthesis comprising the steps providing a tanned natural tissue heart valve having a generally cylindrical valve wall, an inflow end, an outflow end, and a plurality of cusps attached to said valve wall adjacent said inflow end of said valve and extending to a position proximal said outflow end, attaching said heait valve within a stent having an inflow end, an outflow end, an annular base portion proximal said stent inflow end, and a plurality of posts extending from said base in a generally parallel and spaced apart relation that generally corresponds to the circumferential positioning of said cusps, said stent further including a generally nonabsorbent textile material covering at least a portion thereof, such that said inflow end of said valve is positioned adjacent said inflow end of said stent with said outflow end of said valve proximal said stent outflow end to define a outflow end of said valve prosthesis; and attaching a pericardium strip to at least a portion of said textile material of said outflow end of said prosthesis to inhibit abrasion between said cusps and said textile material covering said stent
PCT/US1997/000283 1996-01-04 1997-01-03 Heart valve prosthesis and method for making same WO1997024989A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US961196P true 1996-01-04 1996-01-04
US60/009,611 1996-01-04
US08/708,756 1996-09-09
US08/708,756 US5855602A (en) 1996-09-09 1996-09-09 Heart valve prosthesis

Publications (1)

Publication Number Publication Date
WO1997024989A1 true WO1997024989A1 (en) 1997-07-17

Family

ID=26679683

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/000283 WO1997024989A1 (en) 1996-01-04 1997-01-03 Heart valve prosthesis and method for making same

Country Status (1)

Country Link
WO (1) WO1997024989A1 (en)

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001047438A1 (en) * 1999-12-23 2001-07-05 Edwards Lifesciences Corporation Enhanced visualization of medical implants
US6364905B1 (en) 1999-01-27 2002-04-02 Sulzer Carbomedics Inc. Tri-composite, full root, stentless valve
EP1570809A1 (en) * 2004-03-03 2005-09-07 Sorin Biomedica Cardio S.R.L. "Cardiac-valve prosthesis"
WO2008065678A2 (en) * 2006-11-29 2008-06-05 Aparna Thirumalai Anandampilla An improved heart valve
US8006535B2 (en) 2007-07-12 2011-08-30 Sorin Biomedica Cardio S.R.L. Expandable prosthetic valve crimping device
US8353953B2 (en) 2009-05-13 2013-01-15 Sorin Biomedica Cardio, S.R.L. Device for the in situ delivery of heart valves
US8403982B2 (en) 2009-05-13 2013-03-26 Sorin Group Italia S.R.L. Device for the in situ delivery of heart valves
US8512397B2 (en) 2009-04-27 2013-08-20 Sorin Group Italia S.R.L. Prosthetic vascular conduit
AU2012244361B2 (en) * 2000-01-31 2013-08-29 Cook Biotech Incorporated Stent valves and uses of same
US8540768B2 (en) 2005-02-10 2013-09-24 Sorin Group Italia S.R.L. Cardiac valve prosthesis
US8685084B2 (en) 2011-12-29 2014-04-01 Sorin Group Italia S.R.L. Prosthetic vascular conduit and assembly method
US8715207B2 (en) 2009-03-19 2014-05-06 Sorin Group Italia S.R.L. Universal valve annulus sizing device
US8808369B2 (en) 2009-10-05 2014-08-19 Mayo Foundation For Medical Education And Research Minimally invasive aortic valve replacement
US8834563B2 (en) 2008-12-23 2014-09-16 Sorin Group Italia S.R.L. Expandable prosthetic valve having anchoring appendages
US8840661B2 (en) 2008-05-16 2014-09-23 Sorin Group Italia S.R.L. Atraumatic prosthetic heart valve prosthesis
US9149207B2 (en) 2009-03-26 2015-10-06 Sorin Group Usa, Inc. Annuloplasty sizers for minimally invasive procedures
US9161836B2 (en) 2011-02-14 2015-10-20 Sorin Group Italia S.R.L. Sutureless anchoring device for cardiac valve prostheses
US9168105B2 (en) 2009-05-13 2015-10-27 Sorin Group Italia S.R.L. Device for surgical interventions
US9248017B2 (en) 2010-05-21 2016-02-02 Sorin Group Italia S.R.L. Support device for valve prostheses and corresponding kit
US9289289B2 (en) 2011-02-14 2016-03-22 Sorin Group Italia S.R.L. Sutureless anchoring device for cardiac valve prostheses
US9848981B2 (en) 2007-10-12 2017-12-26 Mayo Foundation For Medical Education And Research Expandable valve prosthesis with sealing mechanism
US10058313B2 (en) 2011-05-24 2018-08-28 Sorin Group Italia S.R.L. Transapical valve replacement

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2136533A (en) * 1983-02-08 1984-09-19 Wessex Medical Lab Limited Artificial heart valve

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2136533A (en) * 1983-02-08 1984-09-19 Wessex Medical Lab Limited Artificial heart valve

Cited By (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6364905B1 (en) 1999-01-27 2002-04-02 Sulzer Carbomedics Inc. Tri-composite, full root, stentless valve
US6797000B2 (en) 1999-01-27 2004-09-28 Carbomedics Inc. Tri-composite, full root, stentless valve
WO2001047438A1 (en) * 1999-12-23 2001-07-05 Edwards Lifesciences Corporation Enhanced visualization of medical implants
AU2012244361B2 (en) * 2000-01-31 2013-08-29 Cook Biotech Incorporated Stent valves and uses of same
EP1570809A1 (en) * 2004-03-03 2005-09-07 Sorin Biomedica Cardio S.R.L. "Cardiac-valve prosthesis"
US9867695B2 (en) 2004-03-03 2018-01-16 Sorin Group Italia S.R.L. Minimally-invasive cardiac-valve prosthesis
US9895223B2 (en) 2005-02-10 2018-02-20 Sorin Group Italia S.R.L. Cardiac valve prosthesis
US8920492B2 (en) 2005-02-10 2014-12-30 Sorin Group Italia S.R.L. Cardiac valve prosthesis
US8540768B2 (en) 2005-02-10 2013-09-24 Sorin Group Italia S.R.L. Cardiac valve prosthesis
US9486313B2 (en) 2005-02-10 2016-11-08 Sorin Group Italia S.R.L. Cardiac valve prosthesis
WO2008065678A2 (en) * 2006-11-29 2008-06-05 Aparna Thirumalai Anandampilla An improved heart valve
WO2008065678A3 (en) * 2006-11-29 2008-12-18 Aparna Thirumalai Anandampilla An improved heart valve
US8006535B2 (en) 2007-07-12 2011-08-30 Sorin Biomedica Cardio S.R.L. Expandable prosthetic valve crimping device
US8640521B2 (en) 2007-07-12 2014-02-04 Sorin Group Italia S.R.L. Expandable prosthetic valve crimping device
US9848981B2 (en) 2007-10-12 2017-12-26 Mayo Foundation For Medical Education And Research Expandable valve prosthesis with sealing mechanism
US8840661B2 (en) 2008-05-16 2014-09-23 Sorin Group Italia S.R.L. Atraumatic prosthetic heart valve prosthesis
US8834563B2 (en) 2008-12-23 2014-09-16 Sorin Group Italia S.R.L. Expandable prosthetic valve having anchoring appendages
US10098733B2 (en) 2008-12-23 2018-10-16 Sorin Group Italia S.R.L. Expandable prosthetic valve having anchoring appendages
US9918841B2 (en) 2009-03-19 2018-03-20 Sorin Group Italia S.R.L. Universal valve annulus sizing device
US8715207B2 (en) 2009-03-19 2014-05-06 Sorin Group Italia S.R.L. Universal valve annulus sizing device
US9149207B2 (en) 2009-03-26 2015-10-06 Sorin Group Usa, Inc. Annuloplasty sizers for minimally invasive procedures
US8512397B2 (en) 2009-04-27 2013-08-20 Sorin Group Italia S.R.L. Prosthetic vascular conduit
US8353953B2 (en) 2009-05-13 2013-01-15 Sorin Biomedica Cardio, S.R.L. Device for the in situ delivery of heart valves
US9168105B2 (en) 2009-05-13 2015-10-27 Sorin Group Italia S.R.L. Device for surgical interventions
US8403982B2 (en) 2009-05-13 2013-03-26 Sorin Group Italia S.R.L. Device for the in situ delivery of heart valves
US8808369B2 (en) 2009-10-05 2014-08-19 Mayo Foundation For Medical Education And Research Minimally invasive aortic valve replacement
US9248017B2 (en) 2010-05-21 2016-02-02 Sorin Group Italia S.R.L. Support device for valve prostheses and corresponding kit
US9161836B2 (en) 2011-02-14 2015-10-20 Sorin Group Italia S.R.L. Sutureless anchoring device for cardiac valve prostheses
US9289289B2 (en) 2011-02-14 2016-03-22 Sorin Group Italia S.R.L. Sutureless anchoring device for cardiac valve prostheses
US10058313B2 (en) 2011-05-24 2018-08-28 Sorin Group Italia S.R.L. Transapical valve replacement
US8685084B2 (en) 2011-12-29 2014-04-01 Sorin Group Italia S.R.L. Prosthetic vascular conduit and assembly method
US9138314B2 (en) 2011-12-29 2015-09-22 Sorin Group Italia S.R.L. Prosthetic vascular conduit and assembly method

Similar Documents

Publication Publication Date Title
EP0257874B1 (en) Flexible cardiac valvular support prosthesis
US9089424B2 (en) Aortic annuloplasty ring
AU700530B2 (en) Apparatus for reducing circumference of vascular structure
EP1977719B1 (en) Method of forming an implantable prosthetic valve
US9339381B2 (en) Four-leaflet stented mitral heart valve
EP1542623B1 (en) Suturing ring for implantable heart valve prostheses
JP6514174B2 (en) Endoprosthesis
JP4852421B2 (en) Implantable prosthetic valve with a non-laminar flow
US6736845B2 (en) Holder for flexible heart valve
US6830585B1 (en) Percutaneously deliverable heart valve and methods of implantation
JP3775991B2 (en) Stentless heart valve bioprosthesis with coronary artery raised
US9414922B2 (en) Three-dimensional annuloplasty ring
US4892541A (en) Heart valve prosthesis
US9486306B2 (en) Inflatable annular sealing device for prosthetic mitral valve
EP0474748B1 (en) Biological valvular prosthesis
US6974464B2 (en) Supportless atrioventricular heart valve and minimally invasive delivery systems thereof
US5258023A (en) Prosthetic heart valve
US7367991B2 (en) Conformal tricuspid annuloplasty ring and template
US8500798B2 (en) Rapid deployment prosthetic heart valve
US5824067A (en) Physiologic mitral valve bioprosthesis
JP5203470B2 (en) The stent for fixing positioning of the valve prosthesis at the implantation site in a patient's heart
EP2257242B1 (en) Infundibular reducer devices
US20050038509A1 (en) Valve prosthesis including a prosthetic leaflet
EP0873094B1 (en) Sizing obturator for prosthetic aortic valves
AU2001295074B2 (en) Minimally-invasive annuloplasty repair segment delivery template system

Legal Events

Date Code Title Description
AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase